Molecular Guided Therapy Provides Sustained Clinical Response in Refractory Choroid Plexus Carcinoma

Choroid plexus carcinomas (CPCs) are rare, aggressive pediatric brain tumors with no established curative therapy for relapsed disease, and poor survival rates. TP53 Mutation or dysfunction correlates with poor or no survival outcome in CPCs. Here, we report the case of a 4 month-old female who pres...

Descripción completa

Detalles Bibliográficos
Autores principales: Cornelius, Albert, Foley, Jessica, Bond, Jeffrey, Nagulapally, Abhinav B., Steinbrecher, Julie, Hendricks, William P. D., Rich, Maria, Yendrembam, Sangeeta, Bergendahl, Genevieve, Trent, Jeffrey M., Sholler, Giselle S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5622196/
https://www.ncbi.nlm.nih.gov/pubmed/28993730
http://dx.doi.org/10.3389/fphar.2017.00652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5622196/
https://www.ncbi.nlm.nih.gov/pubmed/28993730
http://dx.doi.org/10.3389/fphar.2017.00652

Ejemplares similares